-

Xevant Releases New eBook Uncovering the Top 4 PBM Trends Reshaping Pharmacy Benefits in 2025

AI-powered insights reveal industry shifts in drug cost management, transparency, and access for PBMs, brokers, consultants, TPAs, health plans, and employers.

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in AI-driven pharmacy benefits optimization, today announced the release of its latest eBook: Top 4 PBM Trends to Watch in 2025 and Beyond. The publication explores four critical trends that are transforming the pharmacy benefits landscape and offers timely strategies for pharmacy benefit managers, brokers, benefits consultants, health plan executives, TPAs, and self-insured employers.

The free eBook is available for download at: https://www.xevant.com/ebook/top-4-pbm-trends-to-watch-in-2025/

Key findings include:

  • The rise of transparent, technology-powered PBM models
  • The explosive growth of GLP-1 therapies and the urgent need for sustainable cost strategies
  • Accelerated adoption of biosimilars — including the upcoming launch of Stelara alternatives
  • The emergence of high-cost gene therapies and innovative payment models like outcome-based contracts and annuities

“These trends aren’t just reshaping the PBM market — they’re forcing a total rethinking of how we manage pharmacy benefits,” said Brandon Newman, CEO of Xevant. “With soaring drug prices and increased regulatory scrutiny, organizations can’t afford to rely on legacy models. This eBook delivers a practical, data-driven look at what’s next and how to get ahead of it.”

The report also outlines how AI is transforming pharmacy analytics, turning months of manual reporting into real-time, automated insights that detect inefficiencies, improve compliance, and reduce drug spend.

Why it matters:

As costs climb and new therapies hit the market, stakeholders across the healthcare ecosystem are under pressure to adapt. This eBook provides strategic guidance for decision-makers seeking to control pharmacy costs while ensuring access, transparency, and measurable outcomes.

Call to Action:

Download the full eBook today at: https://www.xevant.com/ebook/top-4-pbm-trends-to-watch-in-2025/

About Xevant

Xevant is a leader in real-time, AI-powered pharmacy benefits optimization. By automating complex analytics and delivering daily, actionable insights, Xevant empowers PBMs, health plans, and self-insured employers to reduce costs, improve performance, and enhance patient outcomes. With intelligent automation and unmatched transparency, Xevant is redefining how pharmacy benefits are managed. Learn more at www.xevant.com.

Contacts

Media Contact:
Society22 PR
Rachel Moore
xevant@society22pr.com
929.367.8993

Industry:

Xevant

Release Versions
English

Contacts

Media Contact:
Society22 PR
Rachel Moore
xevant@society22pr.com
929.367.8993

More News From Xevant

Xevant Expands Ivim at Work and Introduces New Lower Pricing on Wegovy® and Ozempic® for Employers Nationwide

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced expanded access to new, lower pricing for its employer-focused medical weight-loss program, Ivim at Work, significantly reducing the cost of GLP-1 therapy for self-funded employers, brokers, and PBMs. The enhanced pricing structure is fully optimized through Xevant’s VerX platform, which identifies and delivers the lowest-cost, clinically appropriate options across the pharmacy ecosystem. The update introduces pricing starting at $199 per mont...

Xevant Expands VerX Platform, Delivering AI-Driven Pharmacy Cost Optimization in the Emerging RxTech Era

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced major advances to its VerX™ Platform, unveiling a new set of interconnected systems — Cortex, Pulse, Axis, and Nudge — that together demonstrate the operational reality of RxTech, the emerging technology segment transforming pharmacy benefits to eliminate more than $250 billion in prescription waste and deliver the lowest net cost for medications. Following VerX’s initial debut earlier this summer, Xevant now shows how its AI-driven platform d...

Xevant White Paper Highlights Opportunities for Transparency in PBM Model, Introduces VerX as Breakthrough for Cost Optimization

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits analytics, today announced the release of a new white paper: “Cracking Open the PBM Black Box: Unlocking Transparency and Partnership with VerX.” The report explores the challenges faced by traditional pharmacy benefit manager (PBM) models and highlights how VerX is helping plan sponsors and PBMs align around data-driven insights to improve cost management and Performance. Evolving Challenges in the PBM Model The white paper not...
Back to Newsroom